v3.26.1
Summary of Significant Accounting Policies - Schedule of Anti-Dilutive Warrants (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2026
Schedule of Anti-Dilutive Warrants [Abstract]      
Net loss from beginning of the year to date of Initial Public Offering   $ (1,444,854)
Net income from date of Initial Public Offering to period end 933,274   938,610
Total net loss for the three months ended March 31, 2026 933,274 $ (1,439,518) (506,244)
Accretion of temporary equity to redemption value (1,752,382)   (22,340,419)
Net loss including accretion of temporary equity to redemption value $ (819,108)   $ (22,846,663)